Investigation on the prevalence of thyroid cancer in Graves' patients in northeastern part of Turkey: Is surgery a better option for patients with Graves' disease who develop antithyroid drug-related major adverse events?

Dayanan R., Bilen A., Demirci T., Ciftel S., Ciftel E., Mercantepe F., ...Daha Fazla

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.26, sa.10, ss.3562-3569, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 10
  • Basım Tarihi: 2022
  • Doi Numarası: 10.26355/eurrev_202205_28851
  • Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.3562-3569
  • Anahtar Kelimeler: Graves' disease, Prevalence, Surgical treatment, Anti-thyroid drug, Thyroid cancer, HYPERTHYROIDISM, CARCINOMA, RISK, CYTOLOGY, NODULES
  • Atatürk Üniversitesi Adresli: Evet

Özet

OBJECTIVE: To determine the prevalence of thyroid cancer in Graves' patients who underwent surgical intervention with and without a history of anti-thyroid drug related major adverse events.